ClinicalTrials.gov
public full text
Public Domain
Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
The purpose of this study is to evaluate the efficacy and safety of dapoxetine compared to placebo in men with premature ejaculation and erectile dysfunction who are currently being treated with a phosphodiesterase-5 inhibitor (ie, sildenafil, vardenafil, or tadalafil) for erectile dysfunction.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone#848014
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation#909352
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation#803472
- Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism#1033094
- Prazosin Vibrostimulation Autonomic Dysreflexia and Spinal Cord Injury Study#843288
Record · ID 1140459
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive